Honokiol

和厚朴酚

Report date: 2025/09/19 20:01:00
NME

Base Information

Drug NameHonokiol
Drug Alias NameN/A
ClassificationNatural product/ExtractSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase AKT1 inhibitorsExtracellular-signal-regulated kinase1 inhibitorsExtracellular-signal-regulated kinase 2 inhibitors
TargetsExtracellular-signal-regulated kinase1Serine/threonine-protein kinase AKT1Extracellular-signal-regulated kinase 2
Therapy Area/IndicationsGingival DiseasesCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesThe Methodist Hospital Research Institute
Inactive CompaniesColgate-Palmolive
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsGingival Diseases

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG